BioCurex Inc. - BOCX

BioCurex Inc. (BOCX)
Coverage: September 10, 2009 - March 10, 2010
Featured: September 9, 2009

Let's not mince words here - many of the standard cancer detection tests are just bad. Either they're expensive, slow, or inaccurate (or some combination of all three). BioCurex Inc. (OTCBB: BOCX) has developed a technology that can potentially address all three problems with the cancer screening process. The opportunity BOCX investors could tap through the company's diagnostic equipment isn't a small one either. The cancer detection/screening market is worth about $1 billion each year. Even a small sliver of that pie could reap relatively huge rewards for BioCurex owners; the company's market cap is only about $4 million, so a small investment gives you a large stake in the company's success.

Latest Newsletter Editions

Thu, Feb 11, 2010 @ 12:02 pm
I'm Buying China Recycling Energy (OTC BB: CREG) I'm hanging with my Big 3 China picks through this market correction, and being aggressive where I see opportunity. I have 3 more to add in the next few months. For those of you who have followed my ideas in the China space, you know I own all three of...
Wed, Jan 20, 2010 @ 01:01 pm
Thank You China Banks The DOW is down about 150 points today, suggesting we might be in for a bit of a correction. Fueling the pullback is news out of China- The government has directed China banks to stop making loans for the remainder of January. Further exacerbating the market's temporary love affair...
Sat, Jan 16, 2010 @ 09:01 am
The Biotech Buzz Rerun I looked for some recent small stock biotech winners. Check out the action in ECTE of late. $1.30 to $2.20 this month on increasing volume as the stock climbs the charts. There's a lot of action in these small biotechs right now. Do you believe in reincarnation? In the stock market...
Wed, Jan 13, 2010 @ 11:01 am
The China/Biotech Buzz It's been a very strong week for my China ideas, with several of the top choices delivering strong news and making new all time highs this week. Review and comments on the hot China ideas below. Biotechs are buzzing right now, and a great number of small cap/biotech stocks are...
Wed, Dec 2, 2009 @ 08:12 am
Coming Attractions You might recall an edition I published about a month ago suggesting it was time to step back, take a look at every idea, and set some cash aside to get past tax selling season and into December. The time has come. I suspect December will be a good month in the markets. Small stocks...

Click Here For More Newsletters on BOCX


Latest Blog Entries


Quote Data

Last Trade: Bid: 0.0000
Last Size: 0 Ask: 0.0000
Trade Time: Bid x Ask Size:
Change: +0.0000 (+0.00%) Day's Range: 0.00 - 0.00
Prev Close: 0.0000 52wk Range: 0.00 - 0.00
Open: 0.0000 P/E (ttm):
Volume: 0 EPS (ttm):
spacer [Chart]

Business Summary

BioCurex is a biotechnology company that is developing products based on patented/proprietary technology in the areas of cancer diagnosis, imaging and therapy. The technology identifies a cancer marker known as RECAF(TM), which is found on malignant cells from a variety of cancer types but is absent in most normal or benign cells.


TGR Group LLC, an affiliate of MarketByte LLC, has been paid a fee of 300,000 newly issued restricted shares by Biocurex for coverage of the Company.

Recent News Headlines